Hardy Chan | Founder and Chairman
Allianz Pharmascience | Taiwan

Hardy Chan, Founder and Chairman, Allianz Pharmascience

Hardy Chan is the Chairman & President of Allianz Pharmascience,  Helios Bioelectronics and Chairman & Co-founder of Nano Targeting & Therapy Biopharma. Prior to these roles, he served as the former President of Tanvex Biologics and co-founded ScinoPharm Taiwan, both are well known publicly listed pharma companies in Taiwan.  He was also the former Vice President of Drug Discovery at Syntex Corporation.  

Hardy received his PhD in Biochemistry from University of Wisconsin, Madison.

Appearances:



Biotech Bootcamp @ 11:00

Building an entrepreneurial management team

Biotech Bootcamp @ 12:00

Breakout group discussion 1

Attendees to break into group of 3-4 each discussing on a specific topic for 25 minutes. Each group will be given 5 minutes to present on 3 key learning from the brainstorm session.

Topic 1: Beyond creativity: Systematic approach to build a successful business
Hardy Chan, Chairman & President of Allianz Pharmascience, Co-founder and senior advisor of ScinoPharm, Taiwan

Topic 2: Innovation process in product development and company building
Shwen Gwee, Head of Digital Strategy, Global Clinical Operations, Biogen, USA

Topic 3: Essential ingredients and options in funding the business
Hui Hsing Ma, Senior Deal Advisor, SEA, TVM Capital Healthcare, Singapore

Topic 4: Building the right partnership to accelerate, de-risk and sustain business relationship
Bien Kiat Tan, Founder, Titan Capital, Singapore

back to speakers